Breast asymmetry after cancer treatment affects quality of life, U-M study finds

July 08, 2008

ANN ARBOR, Mich. -- Most women with breast cancer assume that surgery to preserve their breast will be less disfiguring than a mastectomy that removes the entire breast.

But nearly one-third of women reported pronounced asymmetry between their breasts, and that perceived disfigurement greatly affects a woman's quality of life after treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

The researchers found that compared to women with little to no breast asymmetry, women whose affected breast looked significantly different were twice as likely to fear their cancer recurring and to have symptoms of depression. These women were also more likely to perceive themselves as less healthy and to feel stigmatized by their breast cancer treatment.

"We found that one of the most important factors of post-operative quality of life and satisfaction was post-operative asymmetry or the aesthetic outcome that women experienced after their surgery," says lead study author Jennifer Waljee, M.D., M.P.H., a resident in general surgery at the U-M Medical School.

Results of the study appear in the July 10 Journal of Clinical Oncology.

Many women who are diagnosed with breast cancer will have a choice between breast conserving surgery, in which just the tumor and a margin of surrounding tissue are removed, and mastectomy, which removes the entire breast. Reconstructive surgery is an option after mastectomy but also can help correct asymmetry from breast conserving surgery.

"It's important for women to think about all of those issues at the time that they're making their surgical decision and realize that although breast conserving surgery may or may not be less disfiguring than mastectomy, they're likely to experience some asymmetry afterwards that may impact their quality of life," Waljee says.

Typically, surgeons counsel mastectomy patients before surgery on the types of aesthetic changes they can expect. Women who undergo breast conserving surgery may not be receiving the same level of counseling, the researchers suggest, leaving them with inaccurate expectations of what their breast will look like after surgery.

"It's important for breast surgeons to have an open and honest dialog with their patients so that they understand patients' expectations before surgery and can better address post-operative recovery needs," Waljee says.

In the United States, 182,460 women will be diagnosed with breast cancer this year and 40,480 will die from the disease, according to the American Cancer Society.
-end-
Methodology: The authors mailed surveys to all women who underwent breast conserving surgery at the University of Michigan Health System between January 2002 and May 2006; 714 women responded.

Additional authors: Emily S. Hu, M.D., U-M plastic surgery; Peter A. Ubel, M.D., U-M internal medicine and VA Ann Arbor Healthcare System; Dylan M. Smith, Ph.D., U-M internal medicine and VA Ann Arbor Healthcare System; Lisa A. Newman, M.D., M.P.H., U-M general surgery; and Amy K. Alderman, M.D., M.P.H., U-M plastic surgery.

Funding source: Robert Wood Johnson Clinical Scholars Program at the University of Michigan

Reference: Journal of Clinical Oncology, Vol. 26, Issue 20, July 10, 2008

Resources:

U-M Cancer AnswerLine: 800-865-1125
U-M Breast Care Clinic: www.cancer.med.umich.edu/cancertreat/breast/the_clinic.shtml
National Cancer Institute: www.cancer.gov/cancertopics/types/breast
American Cancer Society: www.cancer.org

Contact:

Nicole Fawcett, nfawcett@umich.edu, or Krista Hopson, khopson@umich.edu, 734-764-2220

University of Michigan Health System

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.